As a tumour suppressor, the protein p16INK4a (also known as p16) inhibits the activity of cyclin-dependent kinases (CDKs) and slows cell division by delaying the transition from the G1 to the S phases of the cell cycle [124]. This evidence concerns the gene CDKN2A and neoplasm.